Details
Category: Volume 10 Issue 02 February 2022
Hits: 487

Title: A Prospective Study to Compare Chemotherapy and Radiotherapy in Palliative Treatment of Locally Advanced Carcinoma Gall Bladder

Authors: Avinash Ranjan, S.N. Prasad, Jitendra Verma, Pramod Kr Singh, Archana Singh, Md. Waseem Raza

 DOI: https://dx.doi.org/10.18535/jmscr/v10i2.28

Abstract

Background: Currently, there is no standard therapy for advanced gallbladder cancer. In patients who are beyond the scope of curative treatment at the time of diagnosis, palliative chemotherapy and palliative radiotherapy can be prescribed but the survival is counted in months and the quality of life is further hampered due to toxicity of drugs.

Objective: With respect to response and acute toxicities we evaluated the efficacy and toxicities of radiotherapy and chemotherapy in three arms. We compared the loco regional response in 3 arms after completion of treatment and at the end of 2 months and 6 months of radiotherapy and chemotherapy.

Material and Methods: Sixty patients of surgically unresectable locally advanced carcinoma gall bladder were enrolled. They were randomized in three arms. Arm A received radiotherapy 30 Gy in 10 fractions, Arm B received radiotherapy 20 Gy in 5 fractions and Arm C received chemotherapy Inj gemcitabine with Inj cisplatin for 6 cycles.

Results: Median follow up of all arms were 8 months. 8 months progression free survival (22% vs 10.5% vs 29.4% p value-0.2010) and overall survival (54% vs 42% vs 51% p value-0.08) were comparable in 3 arms. Hematological toxicities, nausea and vomiting were significantly greater in chemotherapy arm. Locoregional response and QOL were comparable in all 3 arms.

Conclusion: Palliative radiotherapy had comparable locoregional response with significantly lower toxicity profile. Thus, palliative radiotherapy can be considered as an alternative to chemotherapy in treatment of locally advanced carcinoma gall bladder.

Keyword: Gall bladder cancer, palliative chemotherapy, palliative radiotherapy, Inj gemcitabine, Inj cisplatin, locoregional response.

References

  1. Uno, T., et al. "Primary carcinoma of the gallbladder: role of external beam radiation therapy in patients with locally advanced tumor." Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft... [et al] 172.9 (1996): 496-500.
  2. Vij, Jagdish C., et al. "Endoscopic biliary endoprosthesis for palliation of gallbladder carcinoma." Gastrointestinal endoscopy 43.2 (1996): 121-123.
  3. Houry, S., et al. "Gallbladder cancer: role of radiation therapy." Hepatogastroenterology 46.27 (1999): 1578-1584.
  4. Donohue, John H. "Present status of the diagnosis and treatment of gallbladder carcinoma." Journal of Hepato-biliary-pancreatic Surgery 8.6 (2001): 530-534.
  5. Eleftheriadis, N., et al. "Is external palliative radiotherapy for gallbladder carcinoma effective?." Oncology Research and Treatment 24.6 (2001): 581-584.
  6. Houry S, Barrier A, Huguier M (2001) Irradiation therapy for gallbladder carcinoma: recent advances J Hepatobiliary Pancreat Surg 8(6): 518- 524.
  7. Batra, Yogesh, et al. "Gallbladder cancer in India: a dismal picture." Journal of gastroenterology and hepatology 20.2 (2005): 309-314
  8. Ben-David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, et al. (2006) External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 66(3):772-779.
  9. Valle, Juan, et al. "Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer." New England Journal of Medicine 362.14 (2010): 1273-1281.
  10. Sirohi B, Mitra A, Jagannath P, Singh A, Ramadvar M, et al. (2015) Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer. Future Oncol 11(10):1501-1509.
  11. Henley SJ, Weir HK, Jim MA, Watson M, Richardson LC (2015) Gallbladder Cancer Incidence and Death Rates Cancer Epidemiology, Biomarkers and Prevention 24(9): 1319–1326.
  12. Rishi Agarwal, Arun Sendilnathan, Nabeela Iffat Siddiqi, Shuchi Gulati, Abhimanyu Ghose, Changchun Xie, Olugbenga Olanrele Olowokure J Gastrointest Oncol. 2016 Dec; 7(6):996-1003. Doi: 10.21037/jgo.2016. 09.10
  13. Schwartz LH, Litière S, de Vries E, Ford R, Gwyther S, et al. (2016) RECIST 1.1-Update and Clarification: From the RECIST Committee. Eur J Cancer Oxf Engl 1990 62: 132-137.
  14. JW Valle, I Borbath, SA Khan, F Huguet, T Gruenberger, et al. (2016) Biliary Cancer: ESMO Clinical Practice Guidelines 27: v28-v37.
  15. Verma V, Crane CH (2019) Contemporary perspectives on the use of radiation therapy for locally advanced gallbladder cancer. Chin Clin Oncol 8(4): 41-41.
  16. Prashanth Rawla, Tagore Sunkara, Krishna Chaitanya Thandra, Adam Barsouk Clin Exp Hepatol. 2019 May; 5(2): 93–102. Published online 2019 May 23. doi: 10.5114/ceh. 2019.85166.
  17. Shwetabh Sinha1, Reena Engineer, Vikas Ostwal, Anant Ramaswamy, Supriya Chopra, Nitin Shetty, et al (2020) Radiotherapy for Locally Advanced Unresectable Gallbladder Cancer-A Way Forward: Comparative Study of Chemotherapy Versus Chemoradiotherapy. 10.32474/OAJOM.2020.04.000177.
  18. RTOG/EORTC Late Radiation Morbidity Scoring Schema.

Corresponding Author

Avinash Ranjan

Junior Resident IIIrd Year, Department of Radiation Oncology J.K. Cancer Institute, Kanpur, Uttar Pradesh, India